According to Asia Pacific Industrial's announcement, net profit attributable to shareholders of listed companies from January 1, 2026 to June 30, 2026 is estimated to be -2.785,200 yuan to -1,444,800 yuan, an increase of 88.26% to 93.91% over the same period of the previous year; net profit after deducting non-recurring profit and loss is -4.8879 million yuan to -2,5356 million yuan, an increase of 60.71% to 79.62% over the same period last year. The main reason for the increase in net profit for the current period compared to the same period last year was a recovery in the industry cycle, a recovery in demand for pesticides and pharmaceutical intermediates, and an increase in product sales.

According to Asia Pacific Industrial's announcement, net profit attributable to shareholders of listed companies from January 1, 2026 to June 30, 2026 is estimated to be -2.785,200 yuan to -1,444,800 yuan, an increase of 88.26% to 93.91% over the same period of the previous year; net profit after deducting non-recurring profit and loss is -4.8879 million yuan to -2,5356 million yuan, an increase of 60.71% to 79.62% over the same period last year. The main reason for the increase in net profit for the current period compared to the same period last year was a recovery in the industry cycle, a recovery in demand for pesticides and pharmaceutical intermediates, and an increase in product sales.